Lv31
390 积分 2025-04-02 加入
Current developments in gastric cancer: from molecular profiling to treatment strategy
3小时前
已完结
CLDN18.2-targeting antibody-drug conjugate IBI343 in advanced gastric or gastroesophageal junction adenocarcinoma: a phase 1 trial
3小时前
已完结
The antibody-drug conjugate SHR-A1904 for targeting CLDN18.2 in advanced gastric or gastroesophageal junction cancer: a phase 1 trial
3小时前
已完结
Retrospective Study of Claudin 18 Isoform 2 Prevalence and Prognostic Association in Gastric and Gastroesophageal Junction Adenocarcinoma
3小时前
求助中
Progress and challenges in HER2-positive gastroesophageal adenocarcinoma
4小时前
已完结
Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study
4小时前
已完结
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
4小时前
已完结
Cancer incidence and mortality in China, 2022
4小时前
已完结
Validation of the Constipation Risk Assessment Scale (CRAS) in Chinese cancer patients
11天前
已完结
MASCC recommendations on the management of constipation in patients with advanced cancer
12天前
已完结
皖公网安备34019202002308
